Mark C. Schneyer, EVP, CHIEF FINANCIAL OFFICER at ACADIA PHARMACEUTICALS INC (ACAD), sold 2,709 shares at $22.20 ($60K) on 2026-04-07, disclosed to the SEC on 2026-04-07.
Scheduled sale ($60k) by EVP, CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACAD | SELL | 2026-03-26 | $160K | — | Filing → |
| ACAD | SELL | 2025-11-19 | $486K | — | Filing → |
| ACAD | SELL | 2025-09-16 | $165K | — | Filing → |